Latest raise
$55M
Date raised
November 6, 2026
Round
Series A
InvestorsSutter Hill Ventures
About Huafeng Xu
a leading drug design company pioneering the application of quantum chemistry, physics-based molecular simulations, and artificial intelligence to discover and develop next-generation small molecule medicines
- Who is Huafeng Xu?
- Huafeng Xu is listed as Co-founder and Chief Executive Officer of Fathom Therapeutics.
- How much did Fathom Therapeutics raise?
- Fathom Therapeutics raised $55M in a Series A round on November 6, 2026. Backed by Sutter Hill Ventures.
Get newly funded founders every week
A free weekly list of startups that just raised.